Ucb Biopharma
Ucb Biopharma is a Private limited company (Ltd.) registered in Belgium under 0543573053, and its current status with Crossroads Bank for Enterprises (KBO/BCE) is active. The company was incorporated on 24 December 2013 and lists its registered address as Belgium. 1 shareholder is on record for Ucb Biopharma, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last updated on 29 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
Shareholders of Ucb Biopharma
One shareholder is currently on record for Ucb Biopharma, reflecting the registre des actions nominatives (register of registered shares) maintained under the Code des sociétés et des associations rather than a public filing. The largest of these is UCB Pharma SA, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data-provider feed — rows as supplied to Zavia for Crossroads Bank for Enterprises (KBO/BCE), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| UCB Pharma SA | 100% | Crossroads Bank for Enterprises (KBO/BCE) |
Officers
5
Directors and officers of Ucb Biopharma
Four of the 5 officer records shown for Ucb Biopharma are current appointments, filed with Crossroads Bank for Enterprises (KBO/BCE). Alistair Henry (appointed 2024-07-01), Mark Mc Dade, Detlef Thielgen and Ismail Kola all serve as Director. The remaining 1 record shown (Dhavalkumar Patel) is a former appointment that has since been resigned. Management authority at Ucb Biopharma sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 10 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Data-provider feed — rows as supplied to Zavia for Crossroads Bank for Enterprises (KBO/BCE), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Group Structure
Group structure of Ucb Biopharma
Ucb Biopharma sits 2 levels below its ultimate parent, U C B, registered in Belgium. 1 subsidiary is recorded beneath it, across 2 jurisdictions. The full chain up to U C B is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Ucb Biopharma's own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- UCB BIOPHARMA SRL (United Kingdom)
Data availability
Those 1 subsidiary spans Belgium, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Data-provider feed — rows as supplied to Zavia for Crossroads Bank for Enterprises (KBO/BCE), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
U C B
Belgium
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Ucb Biopharma?
One shareholder is currently on record for Ucb Biopharma, reflecting the registre des actions nominatives (register of registered shares) maintained under the Code des sociétés et des associations rather than a public filing. The largest of these is UCB Pharma SA, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Ucb Biopharma's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Ucb Biopharma is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Ucb Biopharma have on record?
1 shareholder is shown on record for Ucb Biopharma.
What is Ucb Biopharma's company registration number?
Ucb Biopharma's registration number is 0543573053, filed with Crossroads Bank for Enterprises (KBO/BCE) in Belgium. Its current status on the register is active.
Is Ucb Biopharma still an active company?
Ucb Biopharma's status on Crossroads Bank for Enterprises (KBO/BCE) is listed as active.
When was Ucb Biopharma incorporated?
Ucb Biopharma was incorporated on 24 December 2013, according to Crossroads Bank for Enterprises (KBO/BCE).
What is Ucb Biopharma's registered address?
The registered address on file for Ucb Biopharma is Belgium.
What legal structure is Ucb Biopharma registered as?
Ucb Biopharma is registered as a Private limited company (Ltd.) in Belgium.
Who are the officers/directors of Ucb Biopharma?
Four of the 5 officer records shown for Ucb Biopharma are current appointments, filed with Crossroads Bank for Enterprises (KBO/BCE). Alistair Henry (appointed 2024-07-01), Mark Mc Dade, Detlef Thielgen and Ismail Kola all serve as Director. The remaining 1 record shown (Dhavalkumar Patel) is a former appointment that has since been resigned. Management authority at Ucb Biopharma sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Ucb Biopharma have a parent company or subsidiaries?
Ucb Biopharma sits 2 levels below its ultimate parent, U C B, registered in Belgium. 1 subsidiary is recorded beneath it, across 2 jurisdictions. Those 1 subsidiary spans Belgium, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Ucb Biopharma's ownership over time?
This profile reflects a point-in-time snapshot from Crossroads Bank for Enterprises (KBO/BCE). Zavia's monitoring API can track changes to Ucb Biopharma's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Ucb Biopharma's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Belgium, so records like Ucb Biopharma's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last synced on 29 September 2026.